Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults
Authors:
- 2 August 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (8) , e2120951
Abstract
With an estimated incidence of 13 130 new diagnoses in 2020, sarcomas are rare tumors that represent approximately 1% of new cancer diagnoses in the United States.1 A diagnosis of sarcoma is not limited to any age, representing 10% of cancers in the adolescent and young adult population.2 Sarcomas are grouped based on origin in soft tissues or bone. Although bone sarcomas are less common than soft-tissue sarcomas overall,2 the incidence of bone sarcomas peak in the young adult age group.3 There are approximately 100 histologic subtypes of sarcoma according to the World Health Organization classification.4 Distinct subtypes with higher incidence in the young adult population are osteosarcoma and Ewing sarcoma.5 Despite the number of young adults with sarcoma, this group is underrepresented in clinical trials.6 Patients with these rare tumors are difficult to study via randomized clinical trials, and the limited data are often extrapolated to young adults. Given poorer outcomes among the young adult population compared with the older adult and pediatric populations,7 there is much debate on optimal treatment regimens for this age group. The relatively poor prognosis can be attributed to multiple factors, including location of care, patient education, differing predominant histology, poor clinical trial participation, and a lack of a designated care system.8-10 Young adults present many complex challenges that affect clinical management. To further identify practice and treatment disparities among the young adult group, the National Cancer Database (NCDB) was used to identify patients 18 years and older with extremity soft-tissue sarcoma (ESS) diagnosed between 2004 and 2014 and treated definitively with limb-sparing surgery (LSS) or amputation. We hypothesized that the NCDB could detect unique factors that are associated with treatment decisions in young adults with ESS.Keywords
This publication has 13 references indexed in Scilit:
- Adolescent and Young Adult Cancer SurvivalJNCI Monographs, 2014
- Cancer2014
- Racial and Ethnic Disparities in the Incidence and Trends of Soft Tissue Sarcoma Among Adolescents and Young Adults in the United States, 1995–2008Journal of Adolescent and Young Adult Oncology, 2013
- Epidemiology and therapies for metastatic sarcomaClinical Epidemiology, 2013
- The Epidemiology of SarcomaClinical Sarcoma Research, 2012
- A Comparison of Clinical Trial Enrollment Between Adolescent and Young Adult (AYA) Oncology Patients Treated at Affiliated Adult and Pediatric Oncology CentersJournal of Pediatric Hematology/Oncology, 2009
- Delays in diagnosis and treatment among children and adolescents with cancer in CanadaPediatric Blood & Cancer, 2008
- The challenges of clinical trials for adolescents and young adults with cancerPediatric Blood & Cancer, 2008
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- National survival trends of young adults with sarcomaCancer, 2005